Vera Therapeutics Inc. Insider Trading
VERA
Insiders bought 250K and sold $8.44M on the open market.
83% of the selling was scheduled in advance under 10b5-1 plans.
Get an email when VERA's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15 | Marshall Fordyce President and CEO | Sold10b5-1 plan | 18,500 | $37.00 | 685K | 7.3% | Form 4 |
| Sep 2 | Marshall Fordyce President and CEO | Sold10b5-1 plan | 18,500 | $35.12 | 650K | 7.3% | Form 4 |
| Jul 7 | Marshall Fordyce President and CEO | Sold10b5-1 plan 4 parts | 46,250 | $42.29 average | $1.96M | 16% | Form 4 |
| Jun 23 | Marshall Fordyce President and CEO | Sold10b5-1 plan 2 parts | 18,500 | $37.93 average | 702K | 7.3% | Form 4 |
| May 12 | Marshall Fordyce President and CEO | Sold10b5-1 plan 2 parts | 18,500 | $36.74 average | 680K | 7.3% | Form 4 |
| Apr 14 | Marshall Fordyce President and CEO | Sold10b5-1 plan 3 parts | 22,951 | $44.05 average | $1.01M | 4.8% | Form 4 |
| Feb 23 | Laurence Matthew Skelton Chief Commercial Officer | SoldNo plan | 1,582 | $41.98 | 66K | 2.4% | Form 4 |
| Feb 23 | Robert Brenner Chief Medical Officer | SoldNo plan | 2,151 | $41.98 | 90K | 4.1% | Form 4 |
| Feb 23 | Sean Grant Chief Financial Officer | SoldNo plan | 4,949 | $41.98 | 208K | 4.0% | Form 4 |
| Feb 23 | Joseph R Young SVP, Finance, Chief Acct Offcr | SoldNo plan | 3,117 | $41.98 | 131K | 4.6% | Form 4 |
| Feb 23 | Marshall Fordyce President and CEO | SoldNo plan | 16,925 | $41.98 | 711K | 3.4% | Form 4 |
| Feb 23 | William D. Turner Chief Regulatory Officer | SoldNo plan | 2,187 | $41.98 | 92K | 4.6% | Form 4 |
| Feb 23 | David Lee Johnson Chief Operating Officer | SoldNo plan | 2,579 | $41.98 | 108K | 5.3% | Form 4 |
| Dec 15, 2025 | William D. Turner Chief Regulatory Officer | Sold10b5-1 plan | 10,000 | $50.08 | 501K | 31% | Form 4 |
| Dec 11, 2025 | Patrick G Enright Director | Bought | 5,882 | $42.50 | 250K | 0.3% | Form 4 |
| Dec 8, 2025 | William D. Turner Chief Regulatory Officer | Sold10b5-1 plan | 10,000 | $45.31 | 453K | 31% | Form 4 |
| Dec 3, 2025 | William D. Turner Chief Regulatory Officer | Sold10b5-1 plan | 10,000 | $40.00 | 400K | 31% | Form 4 |
| Nov 21, 2025 | Jason S Carter Chief Legal Officer | SoldNo plan | 3,864 | $27.82 | 107K | 7.3% | Form 4 |
| Nov 11, 2025 | Joseph R Young SVP, Finance, Chief Acct Offcr | SoldNo plan | 15,000 | $29.06 | 436K | 21% | Form 4 |
| Jun 23, 2025 – Jun 24, 2025 | Patrick G Enright Director | Bought 4 parts | 250,000 | $21.11 average | $5.28M | 7.5% | Form 4 |
| Feb 21, 2025 – Feb 26, 2025 | Marshall Fordyce President and CEO | Sold10b5-1 plan 3 parts | 19,688 | $27.78 average | 547K | 4.4% | Form 4 |
| Jan 8, 2025 | Marshall Fordyce President and CEO | Sold10b5-1 plan 3 parts | 17,500 | $41.74 average | 730K | 4.6% | Form 4 |
| Dec 18, 2024 | Marshall Fordyce President and CEO | Sold10b5-1 plan 5 parts | 17,500 | $43.07 average | 754K | 4.6% | Form 4 |
| Dec 11, 2024 | Marshall Fordyce President and CEO | Sold10b5-1 plan 4 parts | 17,500 | $46.94 average | 822K | 5.4% | Form 4 |
| Nov 25, 2024 | Marshall Fordyce President and CEO | Sold10b5-1 plan 5 parts | 19,375 | $47.98 average | 930K | 5.9% | Form 4 |
- Sep 1510b5-1 planMarshall FordycePresident and CEO · sold 18,500 at $37.00685K7.3% of stake
- Sep 210b5-1 planMarshall FordycePresident and CEO · sold 18,500 at $35.12650K7.3% of stake
- Jul 710b5-1 planMarshall FordycePresident and CEO · sold 46,250 at avg $42.29$1.96M16% of stake
- Jun 2310b5-1 planMarshall FordycePresident and CEO · sold 18,500 at avg $37.93702K7.3% of stake
- May 1210b5-1 planMarshall FordycePresident and CEO · sold 18,500 at avg $36.74680K7.3% of stake
- Apr 1410b5-1 planMarshall FordycePresident and CEO · sold 22,951 at avg $44.05$1.01M4.8% of stake
- Feb 23No planLaurence Matthew SkeltonChief Commercial Officer · sold 1,582 at $41.9866K2.4% of stake
- Feb 23No planRobert BrennerChief Medical Officer · sold 2,151 at $41.9890K4.1% of stake
- Feb 23No planSean GrantChief Financial Officer · sold 4,949 at $41.98208K4.0% of stake
- Feb 23No planJoseph R YoungSVP, Finance, Chief Acct Offcr · sold 3,117 at $41.98131K4.6% of stake
- Feb 23No planMarshall FordycePresident and CEO · sold 16,925 at $41.98711K3.4% of stake
- Feb 23No planWilliam D. TurnerChief Regulatory Officer · sold 2,187 at $41.9892K4.6% of stake
- Feb 23No planDavid Lee JohnsonChief Operating Officer · sold 2,579 at $41.98108K5.3% of stake
- Dec 15, 202510b5-1 planWilliam D. TurnerChief Regulatory Officer · sold 10,000 at $50.08501K31% of stake
- Dec 11, 2025Patrick G EnrightDirector · bought 5,882 at $42.50250K0.3% of stake
- Dec 8, 202510b5-1 planWilliam D. TurnerChief Regulatory Officer · sold 10,000 at $45.31453K31% of stake
- Dec 3, 202510b5-1 planWilliam D. TurnerChief Regulatory Officer · sold 10,000 at $40.00400K31% of stake
- Nov 21, 2025No planJason S CarterChief Legal Officer · sold 3,864 at $27.82107K7.3% of stake
- Nov 11, 2025No planJoseph R YoungSVP, Finance, Chief Acct Offcr · sold 15,000 at $29.06436K21% of stake
- Jun 23, 2025 – Jun 24, 2025Patrick G EnrightDirector · bought 250,000 at avg $21.11$5.28M7.5% of stake
- Feb 21, 2025 – Feb 26, 202510b5-1 planMarshall FordycePresident and CEO · sold 19,688 at avg $27.78547K4.4% of stake
- Jan 8, 202510b5-1 planMarshall FordycePresident and CEO · sold 17,500 at avg $41.74730K4.6% of stake
- Dec 18, 202410b5-1 planMarshall FordycePresident and CEO · sold 17,500 at avg $43.07754K4.6% of stake
- Dec 11, 202410b5-1 planMarshall FordycePresident and CEO · sold 17,500 at avg $46.94822K5.4% of stake
- Nov 25, 202410b5-1 planMarshall FordycePresident and CEO · sold 19,375 at avg $47.98930K5.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with VERA
Held by ETFs
VERA is in 37 US ETFs. The largest of them, with VERA's weight in each:
Spot a number that looks wrong? Check it in VERA's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing VERA
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.